SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (422)10/15/2017 1:15:22 PM
From: ghmm1 Recommendation

Recommended By
scaram(o)uche

  Read Replies (1) of 684
 
Thanks for the background Jim!

On the debt I was more wondering if there is a change of control provision requiring them to pay it before and/or they have an agreement to convert to shares of newco.

GT companies have done quite well of late.. guess I went from thinking them cheap to some seemingly pricing in success of more than their lead program. I'm having trouble finding ones I think aren't pricing in any form of success even at the preclinical level big difference a couple months make! Looking at your list here from a couple months of ago DMTX buy out, 2 reverse mergers into GT companies even ADVM us up a bit.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News